Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Gwolf who wrote (2841)	7/8/1998 8:09:00 PM
From: FatMatty	Read Replies (1) \| Respond to of 5402

Excellent post...that clears up some questions in my head. I couldn't figure out why SGNC seems so different in light of the research posted by chirodoc and others on Flourocarbons Thanks, Matt

To: Gwolf who wrote (2841)	7/8/1998 8:58:00 PM
From: drdan	Respond to of 5402

I'd also like to add that Allance Pharm, the only other company that tried to make a fluorocarbon based product, stopped their research when they found that their product caused hyperinflation of rabbit lungs. So, others have tried, but failed....

To: Gwolf who wrote (2841)	7/8/1998 10:19:00 PM
From: Mr. Forthright	Respond to of 5402

<<Dr. Drees has been keeping this surfactant issue very close to the vest, this is his secret weapon so to speak. This also why he doesn't want to file a patent right now, if he did everyone could see how he has finally accomplished what no one else has been able to do. This all makes more sense now. The major drug companies don't know that he has found a surfactant, that's why their not knocking the doors down right now.>> That is why he is telling a small Internet investor about it.